2006
DOI: 10.1002/mrm.21118
|View full text |Cite
|
Sign up to set email alerts
|

Correlation of proton transverse relaxation rates (R2) with iron concentrations in postmortem brain tissue from alzheimer's disease patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

8
83
1
3

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 98 publications
(95 citation statements)
references
References 35 publications
8
83
1
3
Order By: Relevance
“…90 In a separate study using highresolution 4.7T MRI, this same group of investigators showed a direct correlation between R2 and iron concentrations in postmortem brain tissue obtained from patients with AD. 11 The study also corroborates previous studies demonstrating increased basal ganglia iron levels in patients with AD. 30,32 Collectively these studies suggest that brain gray matter iron deposition may facilitate some of the early neurodegenerative changes seen in AD.…”
Section: Alzheimer's Diseasesupporting
confidence: 90%
See 1 more Smart Citation
“…90 In a separate study using highresolution 4.7T MRI, this same group of investigators showed a direct correlation between R2 and iron concentrations in postmortem brain tissue obtained from patients with AD. 11 The study also corroborates previous studies demonstrating increased basal ganglia iron levels in patients with AD. 30,32 Collectively these studies suggest that brain gray matter iron deposition may facilitate some of the early neurodegenerative changes seen in AD.…”
Section: Alzheimer's Diseasesupporting
confidence: 90%
“…3 A growing body of data suggests that brain iron accumulation in vivo may contribute to tissue damage in a variety of chronic neurological disorders. Histological and magnetic resonance imaging (MRI) data have suggested increases in iron levels in the gray matter in Parkinson's disease (PD), 4 -10 Alzheimer's disease (AD), [11][12][13][14][15][16][17] multiple sclerosis (MS), 18 -21 and a host of other chronic neurological disorders. 22 Consequently, there is a growing interest in optimizing the ability of MRI to estimate iron deposition in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…Given that R2* reflects brain iron content in postmortem samples and in vivo [6][7][8][9][10] , the progressive increase in thalamic R2* is likely to reflect ongoing iron accumulation in neuroferritinopathy, detectable during a 6-to 12-month period. Moreover, the correlation of thalamic R2* with dystonia severity scores supports the use of quantitative MR imaging both to monitor natural history and to study the effects of any treatment aimed at modulating brain iron stores.…”
Section: Discussionmentioning
confidence: 99%
“…Iron decreases the MR T2 decay time and therefore increases the R2 (R2 ϭ 1 /T2), which correlates with iron content in postmortem brain tissue in healthy controls and in neurologic disease. [6][7][8][9][10][11] The R2*(R2* ϭ 1 /T2*) has been shown to be more sensitive than conventional MR imaging in detecting brain iron accumulation. 11 Here we used 3T MR imaging to assess structural changes during a 12-month period on T1 and T2-weighted images and to examine the ability of quantitative R2* (R2* ϭ 1 /T2*) measurement to track iron accumulation in neuroferritinopathy.…”
mentioning
confidence: 99%
“…Its effect on susceptibilityweighted gradient echo MRI techniques increases with field strength (Abduljalil et al, 2003;Duyn et al, 2007). Studies on healthy brains both in vivo and post-mortem suggest that magnetic susceptibility contrast has several contributors, such as myelin (Duyn et al, 2007;Li et al, 2009;Fukunaga et al, 2010), calcium and phospholipid (He and Yablonskiy, 2009), haem-iron (deoxyhaemoglobin) and non-haem iron (Bizzi et al, 1990;Schenck 1995;Gelman et al, 1999;St Pierre et al, 2005;House et al, 2006House et al, , 2007House et al, , 2010; Lee et al, 2009Lee et al, , 2010aShmueli et al, 2009;Yao et al, 2009;Fukunaga et al, 2010). Of these factors, non-haem iron and myelin are both particularly relevant with respect to multiple sclerosis pathology.…”
Section: Introductionmentioning
confidence: 99%